CRC Research Update — August 02, 2026
Today's colorectal cancer research highlights
crc-research
A collection of 723 issues
Evidence-Based Physical Activity Program Developed for Inactive CRC Survivors
Skip to content
The CRC Digest
Evidence-Based Physical Activity Program Developed for Inactive CRC Survivors
Researchers used a Delphi process with 15 experts to develop a comprehensive physical activity promotion intervention for colorectal cancer survivors who do not meet recommended activity levels. (Asia-Pacific Journal of Oncology Nursing)
This content is
Liquid Biopsy Detects ctDNA in 95% of Metastatic CRC Patients
Skip to content
The CRC Digest
▸ TREATMENT
Liquid Biopsy Detects ctDNA in 95% of Metastatic CRC Patients
A Japanese single-center study using Guardant360 CDx found circulating tumor DNA in 18 of 19 metastatic colorectal cancer patients, with a median turnaround time of 11 days and pathogenic alterations identified in 79%
Surgery After Disease Progression May Still Benefit Select Liver Metastasis Patients
Skip to content
The CRC Digest
▸ TREATMENT
Surgery After Disease Progression May Still Benefit Select Liver Metastasis Patients
A Japanese nationwide study analyzed patients from the Colorectal Cancer Liver Metastasis Database who received chemotherapy. (Annals of Surgical Oncology)
This content is informational only and does not constitute medical advice.
Always
Lean Body Mass Linked to Oxaliplatin Neuropathy Risk
Skip to content
The CRC Digest
♥ LIVING WITH CRC
Lean Body Mass Linked to Oxaliplatin Neuropathy Risk
A study of colorectal cancer patients receiving adjuvant CAPOX found that lean body mass and sarcopenia may influence the risk of dose-limiting peripheral neuropathy, suggesting current body-surface-area dosing may not account for important
FDA Approves SimpleScreen CRC Blood-Based Screening Test
Skip to content
The CRC Digest
● REGULATORY
FDA Approves SimpleScreen CRC Blood-Based Screening Test
The FDA has approved SimpleScreen CRC, a new blood-based screening test for colorectal cancer, expanding non-invasive screening options. (The ASCO Post)
This content is informational only and does not constitute medical advice.
Always consult your oncologist
CRC Research Update — August 01, 2026
Today's colorectal cancer research highlights
South Dakota sees shifting trends in early-onset CRC incidence by race
Skip to content
The CRC Digest
South Dakota sees shifting trends in early-onset CRC incidence by race
Analysis of 2007-2022 cancer registry data shows the White population's early-onset CRC incidence rose to 9.6 per 100,000 in 2018-2022, surpassing the American Indian rate and reversing historical patterns.
Deficient mismatch repair is a distinct feature of early-onset CRC in Chinese cohort
Skip to content
The CRC Digest
Deficient mismatch repair is a distinct feature of early-onset CRC in Chinese cohort
Among 4,159 colorectal cancer cases at West China Hospital, early-onset CRC (diagnosed before age 50) showed higher rates of deficient mismatch repair compared to late-onset disease. (Int J Cancer)
This
Traditional Chinese Medicine formula shows benefit for chemotherapy side effects in real-world study
Skip to content
The CRC Digest
♥ LIVING WITH CRC
Traditional Chinese Medicine formula shows benefit for chemotherapy side effects in real-world study
In a propensity-matched analysis of 178 colorectal cancer patients, those receiving a standardized TCM formula alongside fluoropyrimidine chemotherapy had reduced gastrointestinal toxicity and improved quality of life compared